The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on March 30, 2026 for Dr. Harin Haridas Kanani
NEOGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Harin Haridas Kanani, a promoter of Neogen Chemicals Ltd, has created a pledge on 13,19,083 equity shares representing 5% of the company's paid-up capital. The pledge was created on March 30, 2026 to facilitate borrowing or raising of funds by Cadamba Solutions Private Limited, which is a promoter group member of the company. The disclosure has been made under Regulation 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. This is a routine regulatory filing informing about the encumbrance of promoter shares as collateral for a loan to a promoter group entity.
The pledge of 5% of total equity is a routine promoter-level financing arrangement and unlikely to have immediate impact on the stock. However, investors should monitor if the pledged shares are later invoked, which could increase selling pressure.